Database Member Home
RAS Member Home
For two decades Best Practices, LLC has assisted pharmaceutical and bio-pharmaceutical clients with optimizing their marketing activities before, during and after product launch. A series of studies and research tools provided by Best Practices, LLC, analyzing numerous blockbuster products, show that savvy long-term planning can shape a product’s true market potential and dramatically increase its lifetime economic value.
The Launch Assets Database: Benchmarks for Launch Budgets, Activities and Resource Allocation
Our extensive Launch Assets Database contains marketing launch benchmarks from more than 60 leading brands across more than 20 companies.
We can assist you with product planning and lifecycle management by delivering:
As a result, savvy executives are increasingly examining their existing processes to identify opportunities for structural and operational improvement such as:
Over the years, Best Practices, LLC has developed expertise across a broad spectrum of alliances and partnerships topics. Specific research areas include:
This study identifies evidence-based benchmarks on the pros and cons of managing multiple products. The study uncovers the proven tactics for efficiently deploying sales and marketing resources to reduce the costliness of launching and promoting multiple products simultaneously.
This study provides current data on funding levels necessary bring a new product into the U.S. market, during the launch year and for each of the three years preceding product introduction. The study also provides qualitative insights and quantitative metrics that will help companies chart effective budget strategies and allocate funds for new brands.
This study explores the best practices in educating, informing and preparing the marketplace for new diabetes products – through Physician, Patient, and Payer education and publications, advocacy and communication strategies. The study also includes key benchmark metrics, executive insights, and recommendations that Medical Education and Marketing executives can optimize their utilization of current best practices and emerging trends to ensure a successful new product launch.
This study explores the best practices in educating, informing and preparing the marketplace for new oncology products – through Physician, Patient, and Payer education and publications, advocacy and communication strategies.
A past research initiative probed best practices and lessons learned in successful product re-launches. The study also included two highly successful re-launch case studies: the history and lessons learned from Zithromax and Wellbutrin – two blockbuster products that nearly failed in the marketplace during their initial launches. With interviews and extensive survey data drawn from executives at leading pharmaceutical and biotech companies, our research serves as a guide to achieve an excellent product re-launch.
Whether you are looking for ways to improve the brand and lifecycle management of your portfolio or are facing a re-launch of a product that has not achieved its potential upon initial market entry, our team is ready to assist you by identifying the best re-launch practices from the marketing and brand leaders that have directed their re-launched products to blockbuster success.
Specialty pharmaceutical product marketers strive to effectively allocate their resources among various marketing activities and budget categories. Top executives who are marketing specialty products report that detailing, professional relations and market research have the best levels of ROI.
Past research in this area has benchmarked budget allocation, top pre- and post-launch activities, and primary target audiences. Whether you are trying to expand the market or achieve greater market share, Best Practices, LLC can assist you in determining the best pre- and post-launch strategy for your specialty product.
Pharmaceutical companies spend considerable resources conducting large clinical studies to support the launch of new products or expand indications for currently marketed products. Pharmaceutical companies that can leverage that investment by linking the benefits shown in clinical trials to key products will gain significant advantage in the market.
Best Practices, LLC can help your organization benchmark best-in-class companies and uncover the best strategies and tactics for maximizing the impact of clinical trial results.
If this box remains here for more than 30 seconds, click this link to try again.